|Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation|
CN Kotton, D Kumar, AM Caliendo, A Åsberg, S Chou, L Danziger-Isakov, ...
Transplantation 96 (4), 333-360, 2013
|Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments|
MK Gandhi, R Khanna
The Lancet infectious diseases 4 (12), 725-738, 2004
|Immunobiology of human cytomegalovirus: from bench to bedside|
T Crough, R Khanna
Clinical microbiology reviews 22 (1), 76-98, 2009
|International consensus guidelines on the management of cytomegalovirus in solid organ transplantation|
CN Kotton, D Kumar, AM Caliendo, A Åsberg, S Chou, DR Snydman, ...
Transplantation 89 (7), 779-795, 2010
|Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.|
R Khanna, SR Burrows, MG Kurilla, CA Jacob, IS Misko, TB Sculley, ...
The Journal of experimental medicine 176 (1), 169-176, 1992
|Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection|
N Khan, A Hislop, N Gudgeon, M Cobbold, R Khanna, L Nayak, ...
The Journal of Immunology 173 (12), 7481-7489, 2004
|Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers|
R Elkington, S Walker, T Crough, M Menzies, J Tellam, M Bharadwaj, ...
Journal of virology 77 (9), 5226-5240, 2003
|The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.|
HA Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L
|Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease|
R Khanna, S Bell, M Sherritt, A Galbraith, SR Burrows, L Rafter, B Clarke, ...
Proceedings of the National Academy of Sciences 96 (18), 10391-10396, 1999
|An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.|
SR Burrows, R Khanna, JM Burrows, DJ Moss
The Journal of experimental medicine 179 (4), 1155-1161, 1994
|Immune regulation in Epstein-Barr virus-associated diseases.|
R Khanna, SR Burrows, DJ Moss
Microbiological reviews 59 (3), 387-405, 1995
|HLA-B27–restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class i peptide loading|
CA Peh, SR Burrows, M Barnden, R Khanna, P Cresswell, DJ Moss, ...
Immunity 8 (5), 531-542, 1998
|Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases|
R Khanna, SR Burrows
Annual Reviews in Microbiology 54 (1), 19-48, 2000
|Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and …|
M Rowe, R Khanna, CA Jacob, V Argaet, A Kelly, S Powis, M Belich, ...
European journal of immunology 25 (5), 1374-1384, 1995
|Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients|
MK Gandhi, E Lambley, J Duraiswamy, U Dua, C Smith, S Elliott, D Gill, ...
Blood 108 (7), 2280-2289, 2006
|Identification of cytotoxic T cell epitopes within Epstein‐Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype‐restricted immune …|
R Khanna, SR Burrows, J Nicholls, LM Poulsen
European journal of immunology 28 (2), 451-458, 1998
|Epstein–Barr virus‐associated Hodgkin's lymphoma|
MK Gandhi, JT Tellam, R Khanna
British journal of haematology 125 (3), 267-281, 2004
|T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.|
SR Burrows, SL Silins, DJ Moss, R Khanna, IS Misko, VP Argaet
The Journal of experimental medicine 182 (6), 1703-1715, 1995
|Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design|
SA Thomson, R Khanna, J Gardner, SR Burrows, B Coupar, DJ Moss, ...
Proceedings of the National Academy of Sciences 92 (13), 5845-5849, 1995
|Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1|
J Tellam, G Connolly, KJ Green, JJ Miles, DJ Moss, SR Burrows, ...
The Journal of experimental medicine 199 (10), 1421-1431, 2004